FindTrial
Sign In

Study of genetic and protein markers that influence Atopic Dermatitis disease

To determine expression profiles of Atopic Dermatitis biomarkers - SLSID1737

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018554
Enrollment
12
Registered
2019-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Strand Life Sciences Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of Moderate to Severe Atopic Dermatitis 2. Any adult age group, above 18 years 3. ADSI of 6-15 4. Patients willing to provide Informed Consent

Exclusion criteria

Exclusion criteria: 1. Samples from children under 18yrs of age 2. Patients unwilling to provide Informed Consent 3. Patients undergoing treatment for any other severe medical conditions

Design outcomes

Primary

MeasureTime frame
Expression profile of AD biomarkers from skinbiopsyTimepoint: Visit 1—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVinay Paramasivam

Strand Life Sciences Pvt Ltd

suman@strandls.com9591837766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026